Press Releases about Virios Therapeutics Inc![]() ![]() ![]() ![]() ![]()
Virios Therapeutics, Inc. Announces Closing of Public Offering
September 22, 2022
Via Business Wire
![]()
Virios Therapeutics, Inc. Announces Pricing of Public Offering
September 19, 2022
Via Business Wire
![]()
Virios Therapeutics, Inc. Announces Proposed Public Offering
September 19, 2022
Via Business Wire
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
RedChip Partners with Benzinga to Host Exclusive Small-Cap CEO Interview Series on January 28
January 26, 2022
From RedChip
Via AccessWire
![]() ![]() ![]() ![]() ![]()
Virios Therapeutics Granted New Patent for Antiviral Inhibitor Combination
September 08, 2021
Via Business Wire
![]() ![]()
Virios Therapeutics Announces New Social Media Profiles
August 19, 2021
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|